Gamma Pharmaceuticals, Launches Retail Promotions for Gamma Energy Gel(TM) in New York City and Houston

ST PAUL, Minn., Oct. 24, 2011 /PRNewswire/ -- Gamma Pharmaceuticals, Inc. (NASDAQ: GMPM.PK), a vitamin and nutriceuticals marketing and product formulation company, announced the launch of retail promotions for Gamma Energy Gel products in the New York metropolitan area and greater Houston markets. Gamma is pleased to announce sampling events in Houston starting this Wednesday, October 26th and couponing events in New York starting Saturday, October 29th, running for one week and again the week of November 19th. Gamma Energy Gels are available in the Duane Reade division of Walgreens in New York and at leading convenience store and independent retail locations in the Houston Metropolitan area.

Gamma Energy Gels are unique, delivering a burst of energy followed by a long afterglow without the jitters caused by other energy products. Gamma Energy Gels have superior taste and texture, are competitively priced and are designed to not interfere with sleep. Gamma plans to upend the energy product category believing consumers will prefer Gamma Energy Gels over energy drinks and shots. The Company is in the process of adding additional distribution resources and named retail accounts in selected cities, nationwide.

About Gamma Pharmaceuticals, Inc.

Gamma Pharmaceuticals, Inc., (www.gammapharma.com) is a marketing and product formulation company selling its own branded products through wholesalers and direct to retailers, both in the US and internationally. Gamma’s core focus is the marketing and sale of vitamins and nutriceuticals, OTC pharmaceutical products and personal care products in the United States. Branded nutritional supplements are sold under the trademarks Brilliant Choice nutritional supplements featuring the call to action, “You’ve made a brilliant choice for your nutrition;" SAVVY adult nutritional supplements featuring the call to action, “Be SAVVY Stay Healthy;" and, Gamma Energy Products a high performance supplement featuring the call to action, “Get Your Gamma On.” Gamma’s customer focus is on selling products in the Lifestyle of Health & Sustainability (“LOHAS”) marketplace and in the Energy Supplement Market. A series of innovative marketing programs supports Gamma’s product sales and retail partners.

At present Gamma manufactures in North America and distributes in the United States. Gamma’s products utilize proprietary “Gel Delivery Technology®" to create innovative gel product forms that give consumers a more pleasant experience. Gel Delivery Technology® characteristics include rapid absorption, convenience with superior taste and texture. Market categories Gamma targets are growing as rapidly as 60% per year. Gamma has developed formulas and strategies for Metabolic Syndrome and Diabetes Type II, Stress Reduction, Cognition, Well being, Menopause Symptoms and Personal Care Products. Gamma also develops and manufactures house brands for major retailers. At this time, Gamma has a total of 36 SKU’s and holds licenses for 9 SKUs in China.

Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this Press Release regarding any impact the quotation of the Company’s stock has on the Pink Sheets or the lack thereof on the OTCBB, and any other effects of the above are forward-looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

Contact: Gamma Pharmaceuticals, Inc.
Joe Cunningham, CFO (jcunningham@gammapharma.com)
Direct: (651) 204 2048
Office: (702) 989 5262

SOURCE Gamma Pharmaceuticals, Inc.

MORE ON THIS TOPIC